Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed and potentially fatal disease of the heart muscle As it progresses, the heart can become unable to adequately squeeze to pump blood out of the heart, ultimately leading to heart failure
Transthyretin Amyloidosis (ATTR): Symptoms Treatment Transthyretin amyloidosis (ATTR) happens when clumps of irregular proteins build up in tissues like your heart and nerves It can affect other parts of your body, too, like your kidneys and eyes
Understand ATTR-CM TTR Instability - attruby. com ATTR-cardiac amyloidosis (ATTR-CM) is a serious, progressive heart condition Actor portrayals Symptoms About ATTR-CM Diagnosis and Management ATTR-CM happens when TTR Transthyretin, pronounced "trans-thy-retin," or TTR is an important protein that helps transport thyroxine, a thyroid hormone, and retinol (vitamin A) in your body
Diagnosis and treatment of transthyretin‐related amyloidosis . . . Transthyretin‐related amyloidosis (ATTR) is a subgroup of amyloidosis that results from extracellular misassembled and toxic amyloid deposits affecting multiple organ systems, and cardiac tissues in particular Because ATTR often presents as heart
From Treating ATTR-CM to Living with It: A Cardiologists Story . . . March marks Amyloidosis Awareness Month We sat down with Charles, an 88-year-old retired cardiologist from Massachusetts, who shares what it’s like to diagnose and treat heart disease for decades and then face a diagnosis himself His experience with transthyretin amyloid cardiomyopathy (ATTR-CM) offers a unique perspective on this underrecognized condition